ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 73 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $25,001 | -95.5% | 3,193 | -94.5% | 0.00% | -100.0% |
| Q1 2023 | $551,304 | +130.4% | 58,339 | +159.6% | 0.00% | +100.0% |
| Q4 2022 | $239,327 | +40.0% | 22,472 | -2.9% | 0.00% | 0.0% |
| Q3 2022 | $171,000 | +85.9% | 23,155 | +21.6% | 0.00% | 0.0% |
| Q2 2022 | $92,000 | – | 19,037 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Interchange Capital Partners, LLC | 11,420 | $90,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 47,097 | $373,000 | 0.04% |
| GOODWIN DANIEL L | 10,000 | $80,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 99,166 | $784,000 | 0.01% |
| EMFO, LLC | 1,666 | $13,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 34,333 | $272,000 | 0.01% |
| Hartford Financial Management Inc. | 598 | $5,000 | 0.00% |
| Global Financial Private Client, LLC | 266 | $2,059 | 0.00% |
| BLAIR WILLIAM & CO/IL | 51,466 | $407,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 3,808 | $30,000 | 0.00% |